Literature DB >> 21459891

Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.

Colette E Jackson1, Michael R MacDonald, Mark C Petrie, Scott D Solomon, Bertram Pitt, Roberto Latini, Aldo P Maggioni, Beverly A Smith, Margaret F Prescott, Jim Lewsey, John J V McMurray.   

Abstract

AIMS: To examine the relationships between baseline characteristics and urinary albumin excretion in the extensively phenotyped patients in the ALiskiren Observation of heart Failure Treatment (ALOFT) study. METHODS AND
RESULTS: Urinary albumin creatinine ratio (UACR) was available in 190 of 302 (63%) patients randomized in ALOFT. Of these, 107 (56%) had normal albumin excretion, 63 (33%) microalbuminuria, and 20 (11%) macroalbuminuria. Compared with patients with normoalbuminuria, those with microalbuminuria had a greater prevalence of diabetes (48 vs. 26%, P = 0.005) and a lower estimated glomerular filtration rate (eGFR) (60.7 vs. 68.3 mL/min/1.73 m(2), P = 0.01). Patients with macroalbuminuria had additional differences from those with a normal UACR, including younger age (63 vs. 69 years, P = 0.02), higher glycated haemoglobin (HbA1c; 7.9 vs. 6.2%, P < 0.001), and different echocardiographic findings. Of the non-diabetic patients, 28% had microalbuminuria and 7% had macroalbuminuria. Independent predictors of UACR in these patients included N-terminal pro B-type natriuretic peptide (NT-proBNP), HbA1c, and left ventricular diastolic dimension. Increased UACR was not associated with markers of inflammation or of renin angiotensin aldosterone system activation and was not reduced by aliskiren.
CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatinine ratio is independently associated with HbA1c and NT-proBNP, even in non-diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21459891     DOI: 10.1093/eurjhf/hfr031

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  8 in total

1.  Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction.

Authors:  Senthil Selvaraj; Brian Claggett; Sanjiv J Shah; Inder Anand; Jean L Rouleau; Eileen O'Meara; Akshay S Desai; Eldrin F Lewis; Bertram Pitt; Nancy K Sweitzer; James C Fang; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2018-11       Impact factor: 8.790

2.  [Cardiovascular pharmacotherapy and coronary revascularization in end-stage renal failure].

Authors:  L Lauder; S Ewen; I E Emrich; M Böhm; F Mahfoud
Journal:  Herz       Date:  2019-11       Impact factor: 1.443

3.  The risk of death associated with proteinuria in heart failure is restricted to patients with an elevated blood urea nitrogen to creatinine ratio.

Authors:  Meredith A Brisco; Michael R Zile; Jozine M Ter Maaten; Jennifer S Hanberg; F Perry Wilson; Chirag Parikh; Jeffrey M Testani
Journal:  Int J Cardiol       Date:  2016-04-14       Impact factor: 4.164

Review 4.  Novel renal biomarkers to assess cardiorenal syndrome.

Authors:  Meredith A Brisco; Jeffrey M Testani
Journal:  Curr Heart Fail Rep       Date:  2014-12

5.  Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study.

Authors:  Daniel H Katz; Senthil Selvaraj; Frank G Aguilar; Eva E Martinez; Lauren Beussink; Kwang-Youn A Kim; Jie Peng; Jin Sha; Marguerite R Irvin; John H Eckfeldt; Stephen T Turner; Barry I Freedman; Donna K Arnett; Sanjiv J Shah
Journal:  Circulation       Date:  2013-09-27       Impact factor: 29.690

6.  Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction.

Authors:  Daniel H Katz; Jacob A Burns; Frank G Aguilar; Lauren Beussink; Sanjiv J Shah
Journal:  JACC Heart Fail       Date:  2014-10-01       Impact factor: 12.035

7.  Pharmacological interventions for heart failure in people with chronic kidney disease.

Authors:  Meaghan Lunney; Marinella Ruospo; Patrizia Natale; Robert R Quinn; Paul E Ronksley; Ioannis Konstantinidis; Suetonia C Palmer; Marcello Tonelli; Giovanni Fm Strippoli; Pietro Ravani
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

Review 8.  Proteinuria and its relation to cardiovascular disease.

Authors:  Gemma Currie; Christian Delles
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.